Acute myeloid leukemia with the 8q22; 21q22 translocation: secondary mutational events and alternative t (8; 21) transcripts
LF Peterson, A Boyapati, EY Ahn… - Blood, The Journal …, 2007 - ashpublications.org
Blood, The Journal of the American Society of Hematology, 2007•ashpublications.org
Nonrandom and somatically acquired chromosomal translocations can be identified in
nearly 50% of human acute myeloid leukemias. One common chromosomal translocation in
this disease is the 8q22; 21q22 translocation. It involves the AML1 (RUNX1) gene on
chromosome 21 and the ETO (MTG8, RUNX1T1) gene on chromosome 8 generating the
AML1-ETO fusion proteins. In this review, we survey recent advances made involving
secondary mutational events and alternative t (8; 21) transcripts in relation to understanding …
nearly 50% of human acute myeloid leukemias. One common chromosomal translocation in
this disease is the 8q22; 21q22 translocation. It involves the AML1 (RUNX1) gene on
chromosome 21 and the ETO (MTG8, RUNX1T1) gene on chromosome 8 generating the
AML1-ETO fusion proteins. In this review, we survey recent advances made involving
secondary mutational events and alternative t (8; 21) transcripts in relation to understanding …
Abstract
Nonrandom and somatically acquired chromosomal translocations can be identified in nearly 50% of human acute myeloid leukemias. One common chromosomal translocation in this disease is the 8q22;21q22 translocation. It involves the AML1 (RUNX1) gene on chromosome 21 and the ETO (MTG8, RUNX1T1) gene on chromosome 8 generating the AML1-ETO fusion proteins. In this review, we survey recent advances made involving secondary mutational events and alternative t(8;21) transcripts in relation to understanding AML1-ETO leukemogenesis.
ashpublications.org